| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 4 | |
| #2 | Australia | 3 | |
| #3 | Canada | 2 | |
| #4 | New Zealand | 2 | |
| #5 | United States | 2 | |
| #6 | WIPO (World Intellectual Property Organization) | 2 | |
| #7 | South Africa | 2 | |
| #8 | United Kingdom | 1 | |
| #9 | Norway | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Microorganisms | |
| #3 | Fermentation | |
| #4 | Therapeutic chemical compounds | |
| #5 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Kelly Andrew Graham | 12 |
| #2 | Barbas Ana Lucia | 7 |
| #3 | Gnadt Nicole Claudia | 7 |
| #4 | Filipe Susana Melquiades | 6 |
| #5 | Mertens Nico Maurice August Co | 5 |
| #6 | Pissarra Pedro De Noronha | 4 |
| #7 | Macintyre-Ayane Sheila | 3 |
| #8 | Korpela Timo | 3 |
| #9 | Petrovskaya Lada Evgenievna | 2 |
| #10 | De Lorenzo Claudia | 2 |
| Publication | Filing date | Title |
|---|---|---|
| GB201019467D0 | Therapeutic agent | |
| EP1597369A1 | Use of caspase enzymes for maturation of engineered recombinant polypeptide fusions | |
| CA2471042A1 | Expression vectors and promoters for heterologous gene expression | |
| EP1432737A2 | Human mini-antibody cytotoxic for tumor cells which express the erbb2 receptor |